Drug intelligence / Profile preview

A-to-O packed red blood cell conversion system

Development stage
Preclinical
Lead developer
Avivo Biomedical
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Ex Vivo
01

Overview

Avivo Biomedical (formerly ABOzymes Biomedical) is developing an enzyme-based technology for the ex vivo conversion of blood group A packed red blood cells (PRBCs) into group O, the universal donor type. This technology utilizes proprietary enzymes to remove or modify the A antigens on the surface of red blood cells, thereby eliminating blood type incompatibility barriers in transfusions. By converting type A blood into the universal donor type, the platform aims to increase the supply of compatible blood products and reduce the risk of hemolytic transfusion reactions. The program is currently in preclinical development as part of Avivo's broader blood type conversion platform, which also includes applications for organ transplantation.

Other names
A-to-O Packed red blood cell conversionA-to-O PRBC conversionA→O Packed RBC conversion
02

Targets

A antigen (Blood group A antigen)

Beyond the preview

Go deeper on A-to-O packed red blood cell conversion system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A-to-O packed red blood cell conversion system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call